$HCSG

Bundick Jason J sold $458K of HCSG

Bundick Jason J (EVP/Gen. Counsel/Corp. Secty.) sold 18,239 shares of HEALTHCARE SERVICES GROUP INC (HCSG) at $25.11 ($0.46M total) on 2026-10-26.

Original reporting
SEC EDGAR · Bundick Jason J
Published Oct 27, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HCSG
Bearish
medium confidence
Mentioned
$HCSG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HCSGBearishLow
01

Why it matters

The sale reduces insider ownership, which may be interpreted as a negative signal by the market.

02

Market read

Small insider sell with modest potential price impact; relevant for short-term traders monitoring insider activity.

03

What to watch

Potential upcoming corporate actions or compensation plans not disclosed could contextualize the sale.

Relevance 4/10Novelty 4/10Timing: filing date 2026-10-27

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$HCSGBearishMedium confidence
Context

Officer Jason Bundick sold 18,239 shares for $458K, reducing his stake to 17,125 shares.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

A C-level insider sold a notable amount; such sales often lead to modest short-term price weakness.

Market effects

Minimal impact on the healthcare services sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be unrelated to confidence, perhaps for personal liquidity, so price impact may be negligible.

Key entities

  • Jason J. Bundick

    EVP/General Counsel/Corporate Secretary of Healthcare Services Group Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HCSGMed

Healthcare Services Group Inc (HCSG) (Q3 2026) Earnings Call Highlights: Record Revenue

Healthcare Services Group Inc (HCSG) reported Q3 2026 earnings, highlighting record revenue and the NEXDINE acquisition. Challenges include uncertain Genesis bankruptcy recovery ($6.1M estimated), rising SG&A, and unpredictable bad debt. CEO Wahl confirmed low-double-digit 2027 growth outlook, driven by organic momentum and NEXDINE. Q4 revenue guidance includes $150M from NEXDINE. CFO Singh noted SG&A pressure from investments and M&A fees but expects long-term reduction.

$HCSGMed

Healthcare Services Group, Inc. Q3 2026 Earnings Call Summary

Healthcare Services Group (HCSG) reported its ninth straight revenue increase, driven by high retention and new business. The company acquired NEXDINE Hospitality, expanding its senior living and hospitality services. HCSG secured a $6.1 million recovery from Genesis restructuring and raised its 2027 revenue growth outlook to low double digits. Q4 2026 revenue is projected between $535M and $545M, including NEXDINE's $150M contribution. The company also repurchased $11.7M in shares during Q3.

$HCSGMed

HCSG Q3 2026 Earnings Call Transcript

HCSG reported Q3 2026 revenue of $479.6M, with segments Environmental Services at $217.2M (13.3% margin) and Dietary Services at $262.4M (8.7% margin). Q4 2026 revenue is expected to be $535M-$545M, with 2027 revenue growth outlook raised to low double digits. The company reported $24.9M net income ($0.36 EPS) and $30.2M cash flow from operations. HCSG also announced a $6.1M recovery from Genesis restructuring, with potential for higher recovery.

$HCSGMed

What Healthcare Services Group (HCSG) Said on Its Q3 Earnings Call

Healthcare Services Group (HCSG) reported a $3.6M bad-debt benefit in Q3, with adjusted bad-debt expense at $2.5M. CFO Vikas Singh noted SG&A expenses at $48.5M, within target range. The company acquired NEXDINE, expecting $150M annual revenue. Genesis restructuring yielded a $6.1M recovery. HCSG anticipates low-double-digit revenue growth in 2027, with strong cash flow and share repurchases.